Key result
Complete surgical resection is the most effective therapy for primary cardiac malignancies, extending median survival from 6-12 months to 17-24 months, while the role of chemoradiotherapy continues to evolve.
Complete surgical resection remains the most effective therapy for primary cardiac sarcomas, significantly extending median survival compared to untreated patients.
Answers are grounded in this paper and cite their sources.
Supports resection priority in cardiac malignancies based on current data; leaves open chemoradiotherapy optimization requiring randomized evidence.
Malignant cardiac tumors are rare and challenging entity. Experience in treating these aggressive and lethal tumors is minimal and management protocols are not well defined and have to rely on case reports, and personal experiences. Most effective therapy for primary cardiac malignancy is a complete surgical resection and the role of chemoradiotherapy is still evolving.
No takes yet. Share an insight, caveat, or question.
Chauhan et al. (2018) conducted a review in Malignant Cardiac Tumors. Surgical resection and chemoradiotherapy was evaluated. Complete surgical resection is the most effective therapy for primary cardiac malignancies, extending median survival from 6-12 months to 17-24 months, while the role of chemoradiotherapy continues to evolve.
Synapse has enriched 10 related papers. Consider them for comparative context: